Somerville, MA, United States of America

Jonathan W Kotula

This inventor holds 25 USPTO granted patents and 21 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Synthetic Biology. Top assignees: Synlogic Operating Company, Inc., Synlogic, Inc., Harvard College. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan W Kotula. Retrieved from https://idiyas.com/inventor/jonathan-w-kotula

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 21)

% Patents Active = 92.0

CIPO Patents = 1 (Patent Applications = 10)

EPO Patents = 6 (Patent Applications = 18)

Average Co-Inventor Count = 5.9

ph-index = 6

Forward Citations = 126(Granted Patents)

Location History:

Somerville, MA (US) (2016 - 2023)
Berkeley, CA (US) (2021 - 2024)

Company Filing History:

19 out of 24

Synlogic Operating Company, Inc.

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Bacteria Engineering

Metabolic Diseases

Immune Modulators

Gut Inflammation

Hyperphenylalaninemia

Hyperammonemia

Genetic Sensors

Therapeutics

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545886 - BACTERIA FOR THE TREATMENT OF DISORDERS (2026-02-10),

2. 12409195 - Bacteria engineered to reduce hyperphenylalaninemia (2025-09-09),

3. 11896627 - Bacteria engineered to treat metabolic diseases (2024-02-13),

4. 11883439 - Bacteria engineered to treat a disease or disorder (2024-01-30),

5. 11879123 - Bacteria for the treatment of disorders (2024-01-23),

6. 11845964 - Bacteria engineered to treat diseases associated with hyperammonemia (2023-12-19),

7. 11723932 - Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells (2023-08-15),

8. 11685925 - Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier (2023-06-27),

9. 11618894 - Bacteria engineered to reduce hyperphenylalaninemia (2023-04-04),

10. 11471494 - Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells (2022-10-18),

11. 11439673 - Bacteria engineered to treat liver disease (2022-09-13),

12. 11384359 - Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier (2022-07-12),

13. 11291693 - Bacteria engineered to treat metabolic diseases (2022-04-05),

14. 11273184 - Bacteria engineered to treat disorders in which oxalate is detrimental (2022-03-15),

15. 11060073 - Bacteria engineered to treat diseases associated with hyperammonemia (2021-07-13),

Title: Unveiling the Inventive Mind of Jonathan W Kotula

Introduction:

In the city of Somerville, MA (US), resides a prolific inventor by the name of Jonathan W Kotula. With an impressive track record of 23 patents under his belt, Kotula's innovative spirit shines through his groundbreaking work in the field of biotechnology.

Latest Patents:

Kotula's latest patents showcase his expertise in the realm of genetic engineering and pharmaceutical compositions. One notable invention involves genetically engineered bacteria tailored to treat metabolic diseases. Another patent focuses on genetically programmed microorganisms for modulating and treating various diseases and disorders.

Career Highlights:

Having made significant contributions to the field, Kotula's career has been closely intertwined with companies at the forefront of biotechnological advancements. Notable among these are Synlogic Operating Company, Inc. and Synlogic, Inc., where his innovative ideas have been nurtured and brought to fruition.

Collaborations:

In his collaborative efforts, Kotula has worked alongside accomplished individuals such as Dean Falb and Vincent M Isabella. Together, they have pushed the boundaries of scientific discovery, paving the way for novel solutions in the treatment of complex health conditions.

Conclusion:

Jonathan W Kotula's ingenuity and dedication to advancing biotechnological innovation have left an indelible mark on the field. Through his patents and collaborations, he continues to shape the landscape of healthcare with pioneering solutions that have the potential to improve countless lives worldwide.

Profile summary based on public USPTO records.